Deuterated 1-Piperazino-3-Phenyl-INDANES for Treatment of Schizophrenia
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application 61/498,651, filed Jun 20, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,575,174 | Deuterated 1-Piperazino-3-Phenyl-INDANES for Treatment of Schizophrenia In force · High confidence UsedRemaining | H. Lundbeck A/S | In force | High confidence | ||
| US 9,012,453 | Deuterated 1-Piperazino-3-Phenyl Indanes for Treatment of Schizophrenia In force · Medium confidence | H. Lundbeck A/S | In force | Medium confidence | ||
| US 9,216,961 | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia In force · High confidence | H. Lundbeck A/S | In force | High confidence | ||
| US 9,617,231 | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia In force · Low confidence | H. Lundbeck A/S | In force | Low confidence | ||
| US 10,118,907 | Deuterated 1-Piperazino-3-Phenyl Indanes for Treatment of Schizophrenia In force · Low confidence | H. Lundbeck A/S | In force | Low confidence | ||
| US 10,501,427 | Deuterated 1-Piperazino-3-Phenyl Indanes for Treatment of Schizophrenia In force · Low confidence | H. Lundbeck A/S | In force | Low confidence | ||
| US 11,059,798 | Deuterated 1-Piperazino-3-Phenyl Indanes for Treatment of Schizophrenia In force · Low confidence | H. Lundbeck A/S | In force | Low confidence | ||
| US 12,116,355 | Deuterated 1-Piperazino-3-Phenyl Indanes for Treatment of Schizophrenia In force · Low confidence | H. Lundbeck A/S | In force | Low confidence | ||
| Application 18/882,308 | Deuterated 1-Piperazino-3-Phenyl Indanes for Treatment of Schizophrenia Pending Not granted | H. Lundbeck A/S | Pending | Not granted |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
8 of these are in force and held by H. Lundbeck A/S.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.